What are Amneal Pharmaceuticals, Inc.'s profit margins?

Gross margin is 38.7% and operating margin is 14.3%, with a 4.0% net margin.

Where does Amneal Pharmaceuticals, Inc.'s income statement data come from?

Every line is extracted from Amneal Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Amneal Pharmaceuticals, Inc. AMRX Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$3.05B+7.6%	$3.02B+8.0%	$2.93B+9.5%	$2.85B+9.8%	$2.83B+13.4%
Total cost of revenue	$1.87B+4.3%	$1.91B+7.4%	$1.86B+7.1%	$1.78B+5.4%	$1.79B+11.0%
Gross profit	$1.18B+13.4%	$1.11B+9.1%	$1.08B+13.9%	$1.07B+18.0%	$1.04B+17.9%
Gross margin	38.7%+2.0pp	36.9%+0.4pp	36.8%+1.4pp	37.7%+2.6pp	36.7%+1.4pp
Research and development	$184.52M-3.6%	$186.18M-2.4%	$205.62M+12.6%	$203.37M+24.9%	$191.46M+16.3%
Selling, general and administrative	$547.4M+13.5%	$526.83M+10.6%	$509.06M+11.5%	$489.93M+8.6%	$482.13M+9.5%
Operating income	$435.52M+20.8%	$394.1M+58.1%	$357.86M+90.6%	$376.32M+116%	$360.42M+126%
Operating margin	14.3%+1.6pp	13.1%+4.1pp	12.2%+5.2pp	13.2%+6.5pp	12.7%+6.4pp
Interest expense	-$237.51M+4.9%	-$241.09M+6.8%	-$246.52M+3.9%	-$249.21M-3.0%	-$249.83M-10.0%
Other income (expense), net	-$253.62M+16.1%	-$254.89M+16.2%	-$289.2M+7.0%	-$287.02M+1.1%	-$302.42M-13.9%
Income before income taxes	$181.9M+214%	$139.21M+353%	$68.66M+156%	$89.3M+177%	$58M+155%
Income tax expense	$584K-97.7%	$11.28M-40.2%	$11.04M-52.7%	$38.06M+116%	$25.58M+83.5%
Net income	$122.12M+1,036%	$72.06M+162%	$5.9M+103%	$3.38M+102%	-$13.05M+92.3%
Net margin	4%+4.5pp	2.4%+6.6pp	0.2%+7.1pp	0.1%+6.8pp	-0.5%+6.3pp
Diluted earnings per share	$0.38+1,050%	$0.23+161%	$0.02+102%	$0.01+101%	-$0.04+94.5%
EBIT	$435.52M+20.8%	$394.1M+58.1%	$357.86M+90.6%	$376.32M+116%	$360.42M+126%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Amneal Pharmaceuticals, Inc.'s profit margins?: Gross margin is 38.7% and operating margin is 14.3%, with a 4.0% net margin.
Where does Amneal Pharmaceuticals, Inc.'s income statement data come from?: Every line is extracted from Amneal Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.